Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000041699 | SCV000065395 | benign | not specified | 2008-02-20 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000041699 | SCV000169761 | benign | not specified | 2013-08-19 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Eurofins Ntd Llc |
RCV000041699 | SCV000231853 | benign | not specified | 2014-06-26 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000041699 | SCV000317188 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Labcorp Genetics |
RCV001517696 | SCV001726254 | benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001271134 | SCV001748495 | benign | Usher syndrome type 2A | 2021-07-01 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002483031 | SCV002803390 | benign | Usher syndrome type 2A; Retinitis pigmentosa 39 | 2021-10-25 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000041699 | SCV003928752 | likely benign | not specified | 2023-04-16 | criteria provided, single submitter | clinical testing | |
Dept Of Ophthalmology, |
RCV003887883 | SCV004707860 | benign | Retinal dystrophy | 2023-10-01 | criteria provided, single submitter | research | |
Breakthrough Genomics, |
RCV001517696 | SCV005287616 | benign | not provided | criteria provided, single submitter | not provided | ||
Natera, |
RCV001271134 | SCV001451986 | benign | Usher syndrome type 2A | 2020-09-16 | no assertion criteria provided | clinical testing |